1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INHIBIKASE THERAPEUTICS INC
Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Share Price Today, Share Analysis and Chart

about

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

Read More
1.84 0.04 (2.22%)
56.19% Fall from 52W High
32,472
XNAS Volume

XNAS 16 Jul, 2025 12:52 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Neutral
47.6 / 100
Analyst Price Target
No estimates available

5

S

12

W

2

O

0

T

SWOT Analysis

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..